HBP Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.15%

Insider Buying (Last 12 Months): C$17,170.00

Insider Selling (Last 12 Months): C$0.00

Helix BioPharma Insider Trading History Chart

Helix BioPharma Share Price & Price History

C^$2.33

▼ -0.07 (-2.92%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Helix BioPharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/21/2025	Thomas Jorg Heinrich Mehrling	Senior Officer	Buy	17,000	C$1.01	C$17,170.00

SEC Filings (Institutional Ownership Changes) for Helix BioPharma (TSE:HBP)

0.00% of Helix BioPharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.

Today's Range

Now: C$2.33

C$2.33

C$2.40

50 Day Range

MA: C$2.44

C$1.59

C$5.31

52 Week Range

Now: C$2.33

C$0.65

C$5.40

Volume

2,789 shs

Average Volume

6,824 shs

Market Capitalization

C$177.96 million

P/E Ratio

N/A

Dividend Yield

1.50%

Beta

0.215946

Who are the company insiders with the largest holdings of Helix BioPharma?: Helix BioPharma's top insider investors include:
Thomas Jorg Heinrich Mehrling (Senior Officer)
Learn More about top insider investors at Helix BioPharma.